These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11381808)

  • 1. [A new susceptibility gene in Alzheimer's disease].
    Salamanca-Gómez F
    Gac Med Mex; 2001; 137(2):175-6. PubMed ID: 11381808
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease.
    Saltini G; Dominici R; Lovati C; Cattaneo M; Michelini S; Malferrari G; Caprera A; Milanesi L; Finazzi D; Bertora P; Scarpini E; Galimberti D; Venturelli E; Musicco M; Adorni F; Mariani C; Biunno I
    Neurosci Lett; 2006 May; 398(1-2):53-8. PubMed ID: 16412574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetics and Alzheimer's disease].
    Manzano S; González JL; Marcos A; Matías-Guiu J
    Neurologia; 2009 Mar; 24(2):83-9. PubMed ID: 19322684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Alzheimer's disease.
    Burke JR; Roses AD
    Int J Neurol; 1991-1992; 25-26():41-51. PubMed ID: 11980062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis.
    Karlstrom H; Kwok JB; Gregory GC; Hallupp M; Brooks WS; Schofield PR
    Neuroreport; 2007 Aug; 18(12):1267-9. PubMed ID: 17632280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
    Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.
    Carter CJ
    Neurochem Int; 2008 May; 52(6):920-34. PubMed ID: 18164103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered gene expression and neuropathology in Alzheimer's disease.
    Brasnjevic I; Steinbusch HW; Schmitz C
    Neurobiol Aging; 2006 Aug; 27(8):1081-3. PubMed ID: 16111786
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease.
    Poirier J
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S91-7. PubMed ID: 18632009
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene-gene interaction between interleukin-1A and interleukin-8 increases Alzheimer's disease risk.
    Infante J; Sanz C; Fernández-Luna JL; Llorca J; Berciano J; Combarros O
    J Neurol; 2004 Apr; 251(4):482-3. PubMed ID: 15083298
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies.
    Chiappelli M; Tumini E; Porcellini E; Licastro F
    Expert Rev Neurother; 2006 Sep; 6(9):1327-36. PubMed ID: 17009920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virology. Alzheimer's risk factor also aids HIV.
    Youngsteadt E
    Science; 2008 Jun; 320(5883):1577. PubMed ID: 18566258
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's in the family.
    Lemonick MD
    Time; 2003 Dec; 162(22):86-7. PubMed ID: 14666605
    [No Abstract]   [Full Text] [Related]  

  • 14. What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review.
    Ringman JM
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):228-33. PubMed ID: 16306245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection "Junk" DNA - a link to the pathogenesis of Alzheimer's disease?
    MacDonald AB
    Med Hypotheses; 2006; 66(6):1140-1. PubMed ID: 16481123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
    Helisalmi S; Tarvainen T; Vepsäläinen S; Koivisto AM; Hiltunen M; Soininen H
    Neurosci Lett; 2008 Aug; 441(2):233-6. PubMed ID: 18573313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer's: new light shed on genetic factors].
    Nau JY
    Rev Med Suisse; 2011 Apr; 7(291):874-5. PubMed ID: 21604399
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucocorticoid-related genetic susceptibility for Alzheimer's disease.
    de Quervain DJ; Poirier R; Wollmer MA; Grimaldi LM; Tsolaki M; Streffer JR; Hock C; Nitsch RM; Mohajeri MH; Papassotiropoulos A
    Hum Mol Genet; 2004 Jan; 13(1):47-52. PubMed ID: 14583441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA; Hermann B; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of Alzheimer's disease].
    Hiltunen M; Helisalmi S; Kivipelto M; Soininen H
    Duodecim; 2004; 120(20):2425-31. PubMed ID: 15641511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.